KCNJ1 encodes ROMK, an ATP-activated inwardly rectifying potassium channel that plays a crucial role in renal potassium homeostasis 1. This channel is primarily expressed in the thick ascending limb of Henle's loop, where it facilitates potassium recycling essential for sodium-potassium-chloride cotransporter function 1. Loss-of-function mutations in KCNJ1 cause Bartter syndrome type II, typically presenting as severe antenatal disease with polyhydramnios, hypokalemic metabolic alkalosis, and hyperreninemic hyperaldosteronism 23. However, phenotypic variability exists, with rare late-onset cases reported despite identical mutations 2. Beyond its renal function, KCNJ1 appears to have tumor suppressor properties in clear cell renal cell carcinoma, where low expression correlates with poor prognosis and increased metastasis 4. Additionally, KCNJ1 polymorphisms are associated with thiazide-induced glucose changes and new-onset diabetes, likely through potassium-mediated effects on insulin secretion 5. The gene variants may also influence colorectal adenoma risk through interactions with dietary calcium intake 6. These findings highlight KCNJ1's importance in both normal physiology and disease pathogenesis across multiple organ systems.